Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 20
Titolo Tipologia Data di pubblicazione Autori File
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts 02 - Intervento a convegno 2025 Italia, ARomerio, ALami, FGalli,MGranucci, FCosta,B. SPeri, F +
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 02 - Intervento a convegno 2025 Italia, AFranco, A. R.Shaik, M. M.Romerio, A.Lami, F.Peri, FCosta , B. S. +
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection 01 - Articolo su rivista 2025 Romerio A.Peri F. +
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge 01 - Articolo su rivista 2025 Romerio A.Peri F. +
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 01 - Articolo su rivista 2025 Franco, A. R.Romerio, A.Italia, A.Lami, F.Shaik, M. M.Artusa, V.Peri, F. +
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 01 - Articolo su rivista 2024 Shaik M. M.Romerio A.Sesana S.Re F.Bezuidenhout C. X.Bracco S.Peri F. +
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 02 - Intervento a convegno 2024 Italia, A.Franco , AR.Shaik M. M.Romerio, A.Lami, F.Peri, F.Costa, BS. +
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 02 - Intervento a convegno 2024 Lami, FRomerio, AItalia, AShaik, M MPeri, F +
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 01 - Articolo su rivista 2024 Ami D.Franco A. R.Artusa V.Romerio A.Shaik M. M.Italia A.Peri F.Natalello A. +
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 01 - Articolo su rivista 2024 Franco, ARRomerio, AArtusa, VShaik, MMItalia, APeri, F +
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants 07 - Tesi di dottorato Bicocca post 2009 2023 ROMERIO, ALESSIO
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives 02 - Intervento a convegno 2023 Musumeci, RMartinelli, MGiubbi, CPerdoni, FRomerio, AVertemara, JDe Gioia, LPeri, FCocuzza, CE
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 01 - Articolo su rivista 2023 Romerio, AFranco, ARArtusa, VShaik, MMPeri, F +
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 02 - Intervento a convegno 2023 Italia, A.Romerio,A.Shaik, M. M.Costa, B.Peri, F. +
Cleaner synthesis of preclinically validated vaccine adjuvants 01 - Articolo su rivista 2023 Romerio, APeri, F
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 01 - Articolo su rivista 2023 Romerio, AFranco, ARShaik, MMArtusa, VItalia, ALami, FPeri, F +
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 01 - Articolo su rivista 2022 Andrea LuraghiMartina AriciEleonora TorreCarlotta RonchiAlessio RomerioAntonio ZazaMarcella RocchettiFrancesco Peri +
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 06 - Brevetti 2021 Peri, FRomerio, A +
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity 01 - Articolo su rivista 2021 Facchini F. A.Minotti A.Luraghi A.Romerio A.Peri F. +
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview 01 - Articolo su rivista 2020 Romerio, APeri, F
Mostrati risultati da 1 a 20 di 20
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile